吃音治療装置の世界市場-2023年～2030年

吃音の概要

吃音は、失行性、どもり、小児期発症の流暢性障害とも呼ばれます。吃音は、通常の流暢な話し方や話の流れに、頻繁かつ重大な問題を伴う言語障害です。吃音のある人は、言いたいことは分かっていても、それを言うことが困難です。そのため、話の流れが乱れ、間が空いたり、意図しない音が出たり、言葉がつっかえたりします。吃音は通常、小児に発症しますが、どの年齢でも発症する可能性があります。治療可能な症状です。

さらに、電子流暢装置、コミュニケーション装置、音声発生装置、補聴器、吃音防止装置などが吃音症によく使用され、音声の流暢性を改善します。電子流暢装置は、補助装置、電子補助装置、聴覚変化装置、フィードバック装置とも呼ばれ、吃音患者の流暢性を改善することを目的とした電子装置です。ほとんどの電子流暢装置は、患者の耳元で使用者の音声を変化させます。コミュニケーション機器や音声発生機器は、口頭でのコミュニケーションを容易にし、効率を高めるのに役立ちます。

市場力学：促進要因

技術的に高度な機器の採用増加

技術的に高度な機器の採用が増加していることが、予測期間にわたって市場を牽引すると予想されます。人工知能（AI）、仮想現実（VR）、ウェアラブルデバイスなどの技術の継続的な進歩は、高度で快適な機能を備えた吃音治療のための新しく革新的なソリューションを提供します。これらのテクノロジーは、個人に合わせたエクササイズや没入型の体験を提供することができ、これらの先進的なデバイスを使用することでスピーチセラピーの効果を高めることができます。

例えば、2023年06月08日、AONDevicesは、最小限の電力と待ち時間を必要とするアプリケーション向けに設計されたコンパクトで効率的なエッジAIノイズ除去技術であるAONDenoiseを発表しました。AONDenoiseは50Kのパラメータを持ち、利用可能な最小のノイズ除去アルゴリズムの1つで、補聴器、ワイヤレスイヤホン、ウェアラブルで使用するための理想的なAIスピーチエンハンスメントです。

さらに、先進的なデバイスにはユーザーフレンドリーなインターフェイスが搭載されていることが多く、スピーチセラピーを求める個人にとってアクセスしやすく使いやすいものとなっています。ユーザーエクスペリエンスが向上することで、こうした機器の普及が進む可能性があります。先進的な機器は、人工知能を使用して個人の発話パターンを分析し、治療計画をカスタマイズすることができます。パーソナライズされた治療アプローチは、吃音に悩む一人ひとりのユニークなニーズに対応する上で、より効果的であることが多いです。

さらに、補聴器や代替コミュニケーション機器のようなコミュニケーション機器の進歩は、言語療法における機器の採用を改善する可能性が高いです。技術的に進歩した吃音治療装置の有効性に関する調査がさらに進めば、医療専門家はこれらの機器を治療計画に組み込むことをより意識するようになるかもしれません。

例えば、2020年9月1日、コントロール・バイオニクスは、拡張代替コミュニケーション（AAC）装置の最新ライン、グリッドパッド・トリロジー・コミュニケーション・ソリューションを発表しました。タッチコントロール、視線コントロール、NeuroNode 3.0コントロールを同じシステム内で提供するグリッドパッドトリロジーは、ユニークな3-in-1 AACデバイスであり、クライアントとその能力に合わせて進歩し、成長します。他のシステムと比較して、最大133パーセントの速度で、より速いコミュニケーションを可能にします。

さらに、主に小児における吃音の有病率の増加、より適切なデバイスを開発するための臨床試験の増加、言語療法デバイスに関する認知度の向上、新規デバイスの開発における進歩が、予測期間中に市場を牽引すると予想される要因です。

阻害要因

吃音治療装置の使用に伴う合併症やリスク、器具の高価格、背景雑音が大きい環境で頻繁に会話する場合にはこれらの器具がうまく機能しないなどの要因が、市場の妨げになると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 吃音治療装置の普及拡大
  • 抑制要因
    • 装置に伴う合併症とリスク
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• パイプライン分析
• アンメットニーズ
• 特許分析
• DMIのオピニオン

第6章 COVID-19分析

第7章 疾患タイプ別

• 発達性吃音（小児期発症流暢性障害）
• 持続性吃音
• 後天性吃音
  • 神経因性吃音
  • 心因性吃音

第8章 装置タイプ別

• 電子流暢装置
• コミュニケーション機器
• 音声発生装置
• 補聴器
• その他

第9章 エンドユーザー別

• 病院
• 専門クリニック
• 言語療法センター
• 在宅介護
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Takalam Tech
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Casa Futura Technologies
• SpeechEasy
• Tobii Dynavox AB
• PRC-Saltillo
• DrSpectra
• Attainment Company, Inc.
• Lingraphica
• Numotion
• AbleNet, Inc.

第13章 付録

Overview

Stuttering is also known as disfluency, stammering or childhood-onset fluency disorder. It is a speech disorder that involves frequent and significant problems with normal fluency and flow of speech. People who stutter know what they want to say, but have difficulty saying it. This disrupts the flow of speech and causes pauses, unintended sounds and sticking on words. This condition usually affects children but can have impacts at any age. It's a treatable condition.

Moreover, electronic fluency devices, communication devices, speech-generating devices, hearing aids and anti-stammering devices are commonly used in stuttering to improve speech fluency. Electronic fluency devices also known as assistive devices, electronic aids, altered auditory and feedback devices are electronic devices intended to improve fluency for stuttering patients. Most electronic fluency devices change the sound of the user's voice in the patient's ear. Communication devices and speech-generating devices helps to verbally communicate with ease and increase efficiency.

Market Dynamics: Drivers

Increasing adoption of technologically advanced devices

The increasing adoption of technologically advanced devices are expected to drive the market over the forecast period. Continuous advancements in technology, including artificial intelligence (AI), virtual reality (VR), and wearable devices, offer new and innovative solutions for stuttering therapy with advanced and comfortable features. These technologies can provide personalized exercises and immersive experiences, enhancing the effectiveness of speech therapy by using these advanced devices.

For instance, on June 08, 2023, AONDevices launched its AONDenoise, a compact, efficient edge AI denoising technology designed for applications that require minimal power and latency. AONDenoise has 50K parameters, making it one of the smallest denoising algorithms available, and ideal AI speech enhancement for use in hearing aids, wireless earbuds and wearables.

Moreover, advanced devices often come with user-friendly interfaces, making them accessible and easy to use for individuals seeking speech therapy. The improved user experience can contribute to higher adoption of these devices. Advanced devices can use artificial intelligence to analyze individual speech patterns and customize treatment plans. Personalized therapy approaches are often more effective in addressing the unique needs of each person who are suffering from stuttering.

In Addition, the advancements in communication devices like augmentative and alternative communication devices are most likely to improve the adoption of the devices in speech therapy. As more research is conducted on the efficacy of technologically advanced stuttering devices, healthcare professionals may be more aware of integrating these devices into their treatment plans.

For instance, on September 1, 2020, Control Bionics released the newest addition to its Augmentative and Alternative Communication (AAC) device line, the GridPad Trilogy communication solution. Offering touch control, eye control, and NeuroNode 3.0 control within the same system, the GridPad Trilogy is a unique 3-in-1 AAC device that progresses and grows with clients and their abilities. It allows for faster communication, at rates up to 133 percent that of other systems.

Further, the increasing prevalence of stuttering mostly in children, increasing clinical trials to develop more appropriate devices, increasing awareness about the speech therapy devices and advancements in the development of novel devices are the factors expected to drive the market over the forecast period.

Restraints

Factors such as complications and risks associated with the use of stuttering devices, the high cost of the devices and these devices also do not work well when the person is frequently speaking in environments with significant background noise are expected to hamper the market.

Segment Analysis

The global stuttering devices market is segmented based on disease type, device type, end-user and region.

The electronic fluency devices segment accounted for approximately 37.8% of the inflammatory myositis treatment market share

The electronic fluency devices segment is expected to hold the largest market share over the forecast period. Many electronic fluency devices are known to provide real-time auditory feedback to individuals who are suffering from stuttering. This feedback can include altered auditory feedback, which involves modifying the individual's own speech and playing it back in real-time. This process can help individuals become more aware of their speech patterns and make conscious adjustments to improve fluency by avoiding the stuttering.

Additionally, many electronic fluency devices are designed to be portable and discreet. This allows individuals to incorporate the use of these devices into their daily lives without drawing significant attention. Portable devices are particularly convenient for those who want to practice fluency techniques in various settings. These devices can be used in homecare settings according to the patient's priority.

Moreover, these electronic fluency devices either delay or alter the sound of one's voice, creating an echo, or playing some sort of noise, both of which are known to reduce stuttering. However, it is also known that the effects may wear off over time.

Geographical Analysis

North America accounted for approximately 40.1% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption of the devices. North America especially the United States is known for its strong presence of major players such as biotechnology companies and medical device companies which are focussing on the development of the more advanced devices. The presence of major players actively focussing on developing the devices for stuttering.

For instance, on April 14, 2020, the Learning Corp, an award-winning digital therapeutics provider, cleared that it had received Breakthrough Device designation from the United States Food and Drug Administration (FDA) for its Speech Therapy, which is designed to provide accessible cognitive, speech and language therapy to stroke patients.

Moreover, the increasing prevalence of stuttering cases in the region is expected to increase the adoption of stuttering devices in speech therapy. For instance, according to the Stuttering Foundation of America, There are 3 million people in the United States suffering from stuttering. This increasing prevalence is increasing the demand for stuttering devices.

Competitive Landscape

The major global players in the stuttering devices market include: Takalam Tech, Casa Futura Technologies, SpeechEasy, Tobii Dynavox AB, PRC-Saltillo, DrSpectra, Attainment Company, Inc., Lingraphica, Numotion and AbleNet, Inc. among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global stuttering devices market. The pandemic led to disruptions in global supply chains, affecting the production and distribution of stuttering devices. The pandemic accelerated the adoption of telehealth services. While this shift facilitated the remote healthcare consultations, it also influenced the types of interventions and devices that could be effectively utilized during virtual sessions, potentially impacting the use of certain stuttering devices.

Market Segmentation

By Disease Type

• Developmental Stuttering (Child-Onset Fluency Disorder)
• Persistent Stuttering
• Acquired Stuttering
  • Neurogenic Stuttering
  • Psychogenic Stuttering

By Device Type

• Electronic Fluency Devices
• Communication Devices
• Speech Generating Devices
• Hearing Aids
• Others

By End-User

• Hospitals
• Specialty Clinics
• Speech Therapy Centers
• Homecare Settings
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Why Purchase the Report?

• To visualize the global stuttering devices market segmentation based on disease type, device type, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of stuttering devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global stuttering devices market report would provide approximately 61 tables, 61 figures, and 187 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Disease Type
• 3.2. Snippet by Device Type
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Adoption of Stuttering Devices
  • 4.1.2. Restraints
    • 4.1.2.1. Complications and Risks Associated with the Devices
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Pipeline Analysis
• 5.6. Unmet Needs
• 5.7. Patent Analysis
• 5.8. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Disease Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  • 7.1.2. Market Attractiveness Index, By Disease Type
• 7.2. Developmental Stuttering (Child-Onset Fluency Disorder) *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Persistent Stuttering
• 7.4. Acquired Stuttering
  • 7.4.1. Neurogenic Stuttering
  • 7.4.2. Psychogenic Stuttering

8. By Device Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 8.1.2. Market Attractiveness Index, By Device Type
• 8.2. Electronic Fluency Devices*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Communication Devices
• 8.4. Speech Generating Devices
• 8.5. Hearing Aids
• 8.6. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Specialty Clinics
• 9.4. Speech Therapy Centers
• 9.5. Homecare Settings
• 9.6. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Takalam Tech*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Casa Futura Technologies
• 12.3. SpeechEasy
• 12.4. Tobii Dynavox AB
• 12.5. PRC-Saltillo
• 12.6. DrSpectra
• 12.7. Attainment Company, Inc.
• 12.8. Lingraphica
• 12.9. Numotion
• 12.10. AbleNet, Inc.

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us